OFIX
Orthofix Medical Inc.
$10.29
-0.48%
$415.9M
No data for this timeframe.
Vol
Market Cap$415.9M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (73%)
Inst. Holders7 funds
Inst. Value$50.5M
Inst. Activity2 buys / 0 sells
Insider Activity8B / 17S
Insider Net $$650.9K
SEC Reports7
Recent Activity
May 22, 2026
Insider
Juniper Investment Company, LLC sold 242,000 shares
10%+ Owner @ $10.70 ($2.6M)
May 21, 2026
SEC
Orthofix disclosed that CMS updated billing requirements for non-invasive bone growth stimulators, effective May 18, 202
8-K — Impact 7/10
May 21, 2026
short_volume
Short Volume: OFIX — 57.6% short (0.3M / 0.6M)
Short: 342,000 | Exempt: 22,825 | TRF Vol: 593,838 | Short Ratio: 57.6% | Off-exchange volume (dark
May 7, 2026
Insider
Engine Capital Management, LP bought 18,192 shares
10%+ Owner @ $12.20 ($221.9K)
May 7, 2026
Insider
HENNEMAN JOHN B III bought 5,000 shares
Director @ $12.26 ($61.3K)
May 5, 2026
SEC
Orthofix reported Q1 2026 pro forma net sales of $196.4M (+2.7% YoY constant currency) and a GAAP net loss of $(20.9)M,
8-K — Impact 4/10
Apr 29, 2026
SEC
Orthofix Medical Inc. filed additional definitive proxy materials (DEFA14A) reminding shareholders of the June 10, 2026
DEFA14A — Impact 2/10
Inst.
MORGAN STANLEY — ADD
224,643 shares ($3.4M)
Price Targets
$15.00
+45.8% upside
Strong Buy
Current $10.29
Low $12.00
Median $15.00
High $18.00
4 analysts
$12.00
$18.00
Analyst Ratings
4Strong Buy
4Buy
3Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 22, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| May 22, 2026 | Barrington Research | MAINTAIN | Outperform → Outperform |
| May 22, 2026 | Stifel | MAINTAIN | Buy → Buy |
| Apr 10, 2026 | Barrington Research | MAINTAIN | Outperform → Outperform |
| Mar 9, 2026 | Stifel | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.03 | $-0.03 — $-0.03 | -123% YoY | 1 |
| Next FY | $0.71 | $0.03 — $1.39 | 274% YoY | 2 |
| Current FY | $0.19 | $0.19 — $0.19 | -61% YoY | 1 |
| Next Q | $0.05 | $0.05 — $0.05 | -75% YoY | 1 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $34.9M | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $5.1M | NEW |
| BANK OF AMERICA CORP | $4.0M | TRIM |
| MORGAN STANLEY | $3.4M | ADD |
| RENAISSANCE TECHNOLOGIES LLC | $1.2M | NEAR_EXIT |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 22, 2026 | Juniper Investment | SELL | $2.6M |
| May 7, 2026 | Engine Capital | BUY | $221.9K |
| May 7, 2026 | HENNEMAN JOHN | BUY | $61.3K |
| May 6, 2026 | Engine Capital | BUY | $466.5K |
| May 5, 2026 | Engine Capital | BUY | $1.3M |
7 institutional holders with $50.5M total value (3,331,181 shares) as of 2025-Q4. Top holders: VANGUARD, CHARLES, BANK. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 2,304,928 | $34.9M | 69.2% | — |
| 2 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 333,805 | $5.1M | 10.0% | NEW |
| 3 | BANK OF AMERICA CORP /DE/ | 261,386 | $4.0M | 7.8% | TRIM -56.9% |
| 4 | MORGAN STANLEY | 224,643 | $3.4M | 6.7% | ADD +30.3% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | 81,391 | $1.2M | 2.4% | NEAR_EXIT -79.5% |
| 6 | FMR LLC | 81,304 | $1.2M | 2.4% | DOUBLED +3263.2% |
| 7 | WELLS FARGO & COMPANY/MN | 43,724 | $662.9K | 1.3% | ADD +45.9% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 172,405 | 224,643 | +30.3% | $3.4M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 29,969 | 43,724 | +45.9% | $662.9K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 687,410 | 296,254 | -56.9% | $4.3M | 2025-Q3 |
| MORGAN STANLEY | TRIM | 250,184 | 172,405 | -31.1% | $2.5M | 2025-Q3 |
| UBS Group AG | TRIM | 202,100 | 111,350 | -44.9% | $1.6M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 469,201 | 96,091 | -79.5% | $1.4M | 2025-Q3 |
| FMR LLC | DOUBLED | 2,390 | 80,380 | +3263.2% | $1.2M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 90,503 | 687,410 | +659.5% | $7.7M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 91,990 | 469,201 | +410.1% | $5.2M | 2025-Q2 |
| UBS Group AG | DOUBLED | 43,879 | 202,100 | +360.6% | $2.3M | 2025-Q2 |
| FMR LLC | TRIM | 3,455 | 2,390 | -30.8% | $26.6K | 2025-Q2 |
| MORGAN STANLEY | TRIM | 625,051 | 224,820 | -64.0% | $3.7M | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 151,243 | 108,195 | -28.5% | $1.8M | 2025-Q1 |
| UBS Group AG | TRIM | 86,996 | 43,879 | -49.6% | $715.7K | 2025-Q1 |
| MORGAN STANLEY | TRIM | 1,409,684 | 625,051 | -55.7% | $10.9M | 2024-Q4 |
| CITADEL ADVISORS LLC | TRIM | 288,056 | 151,243 | -47.5% | $2.6M | 2024-Q4 |
| UBS Group AG | DOUBLED | 12,916 | 86,996 | +573.6% | $1.5M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 30,791 | 82,190 | +166.9% | $1.4M | 2024-Q4 |
| MORGAN STANLEY | TRIM | 2,022,601 | 1,409,684 | -30.3% | $22.0M | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 324,807 | — | $5.1M | 2024-Q3 |
11 unique insiders with 25 transactions. Net insider value: $650.9K ($3.7M bought, $3.0M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 22, 2026 | Juniper Investment Company, LLC | 10%+ Owner | SELL | 242,000 | $10.70 | $2.6M |
| May 7, 2026 | Engine Capital Management, LP | 10%+ Owner | BUY | 18,192 | $12.20 | $221.9K |
| May 7, 2026 | HENNEMAN JOHN B III | Director | BUY | 5,000 | $12.26 | $61.3K |
| May 6, 2026 | Engine Capital Management, LP | 10%+ Owner | BUY | 38,154 | $12.23 | $466.5K |
| May 5, 2026 | Engine Capital Management, LP | 10%+ Owner | BUY | 110,039 | $11.99 | $1.3M |
| Apr 16, 2026 | Cedron Jorge Andres | CLO | SELL | 3,743 | $12.82 | $48.0K |
| Mar 17, 2026 | Vitale Lucas | CP&BOO | SELL | 4,269 | $11.92 | $50.9K |
| Mar 10, 2026 | CAPPS VICKIE L | Director | BUY | 100 | $12.44 | $1.2K |
| Mar 9, 2026 | CAPPS VICKIE L | Director | BUY | 2,500 | $12.48 | $31.2K |
| Mar 5, 2026 | Andrews Julie | CFO | SELL | 2,363 | $12.55 | $29.7K |
| Mar 5, 2026 | Vitale Lucas | CP&BOO | SELL | 1,141 | $12.55 | $14.3K |
| Mar 5, 2026 | McPherron Aviva | Pres, Global Ops & Qual | SELL | 1,263 | $12.55 | $15.9K |
| Mar 5, 2026 | Cedron Jorge Andres | CLO | SELL | 1,370 | $12.55 | $17.2K |
| Mar 5, 2026 | Calafiore Massimo | President & CEO | SELL | 6,031 | $12.55 | $75.7K |
| Mar 5, 2026 | Fisher Patrick | President, Global Limb Recon | SELL | 758 | $12.55 | $9.5K |
| Mar 5, 2026 | REINHARDT MAX | President, Global Spine | SELL | 1,053 | $12.55 | $13.2K |
| Mar 4, 2026 | Andrews Julie | CFO | SELL | 2,425 | $12.92 | $31.3K |
| Mar 4, 2026 | Calafiore Massimo | President & CEO | SELL | 6,189 | $12.92 | $79.9K |
| Mar 4, 2026 | McPherron Aviva | Pres, Global Ops & Qual | SELL | 1,296 | $12.92 | $16.7K |
| Mar 4, 2026 | Cedron Jorge Andres | CLO | SELL | 1,405 | $12.92 | $18.1K |
| Mar 4, 2026 | Vitale Lucas | CP&BOO | SELL | 1,171 | $12.92 | $15.1K |
| Mar 4, 2026 | Fisher Patrick | President, Global Limb Recon | SELL | 778 | $12.92 | $10.0K |
| Mar 4, 2026 | REINHARDT MAX | President, Global Spine | SELL | 1,080 | $12.92 | $13.9K |
| Mar 3, 2026 | Calafiore Massimo | President & CEO | A | 115,119 | $0.00 | $0.00 |
| Mar 3, 2026 | Calafiore Massimo | President & CEO | A | 273,279 | $0.00 | $0.00 |
| Mar 3, 2026 | McPherron Aviva | Pres, Global Ops & Qual | A | 23,024 | $0.00 | $0.00 |
| Mar 3, 2026 | Vitale Lucas | CP&BOO | A | 45,546 | $0.00 | $0.00 |
| Mar 3, 2026 | Fisher Patrick | President, Global Limb Recon | A | 21,105 | $0.00 | $0.00 |
| Mar 3, 2026 | McPherron Aviva | Pres, Global Ops & Qual | A | 54,656 | $0.00 | $0.00 |
| Mar 3, 2026 | Vitale Lucas | CP&BOO | A | 19,186 | $0.00 | $0.00 |
| Mar 3, 2026 | Fisher Patrick | President, Global Limb Recon | A | 50,101 | $0.00 | $0.00 |
| Feb 25, 2026 | Engine Capital Management, LP | 10%+ Owner | BUY | 9,959 | $12.96 | $129.1K |
| Feb 24, 2026 | Engine Capital Management, LP | 10%+ Owner | BUY | 117,076 | $12.55 | $1.5M |
7 SEC filing reports analyzed. Sentiment: 1 bullish, 2 bearish, 0 mixed, 4 neutral. Avg impact: 4.6/10.
BEARISH
8-K
7/10
Orthofix disclosed that CMS updated billing requirements for non-invasive bone growth stimulators, e
May 21, 2026
NEUTRAL
8-K
4/10
Orthofix reported Q1 2026 pro forma net sales of $196.4M (+2.7% YoY constant currency) and a GAAP ne
May 5, 2026
NEUTRAL
DEFA14A
2/10
Orthofix Medical Inc. filed additional definitive proxy materials (DEFA14A) reminding shareholders o
Apr 29, 2026
BULLISH
8-K
7/10
Orthofix reported preliminary Q1 2026 net sales of $196.7 million (up 1.6% YoY) and reaffirmed its f
Apr 21, 2026
NEUTRAL
CLUSTER
3/10
Lucas Vitale, Chief Planning and Business Operations Officer at Orthofix Medical, sold 4,269 shares
Mar 19, 2026
BEARISH
CLUSTER
6/10
Over the past seven days, multiple executives at Orthofix Medical Inc. (OFIX) sold shares in the ope
Mar 10, 2026
NEUTRAL
CLUSTER
3/10
A cluster of insider transactions at Orthofix Medical Inc. (OFIX) shows two executives, the CLO and
Mar 6, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (73% buy). Based on 11 analysts: 4 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$15.00 mean target
+45.8% upside
Strong Buy (2.00)
$12.00 Low
$18.00 High
| Metric | Value |
|---|---|
| Current Price | $10.29 |
| Target Low | $12.00 |
| Target Mean | $15.00 |
| Target Median | $15.00 |
| Target High | $18.00 |
| # Analysts | 4 |
| Recommendation | Strong Buy (2.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.03 | $-0.03 | $-0.03 | -123.2% | — | 0↑ 1↓ | $0.2B | 3.0% | 1 |
| Next FY 2027-12-31 |
$0.71 | $0.03 | $1.39 | 273.7% | — | 0↑ 1↓ | $0.9B | 5.2% | 2 |
| Current FY 2026-12-31 |
$0.19 | $0.19 | $0.19 | -61.0% | — | 1↑ 0↓ | $0.8B | 2.6% | 1 |
| Next Q 2026-09-30 |
$0.05 | $0.05 | $0.05 | -74.7% | — | 0↑ 1↓ | $0.2B | 2.8% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.030 | |
| 7d ago | $0.000 | -0.030 |
| 30d ago | $0.000 | -0.030 |
| 60d ago | $0.000 | -0.030 |
| 90d ago | $0.115 | -0.145 |
15 analyst firms have rated this stock: 3 upgrades, 8 downgrades, 9 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 22, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| May 22, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| May 22, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Apr 10, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| Mar 9, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Feb 26, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Feb 25, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| Feb 17, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| Jan 27, 2026 | TD Cowen | INITIATE | — | Hold |
| Nov 5, 2025 | Barrington Research | MAINTAIN | Outperform | Outperform |
| Oct 23, 2025 | Barrington Research | MAINTAIN | Outperform | Outperform |
| Sep 23, 2025 | Barrington Research | MAINTAIN | Outperform | Outperform |
| Jun 23, 2025 | Barrington Research | INITIATE | — | Outperform |
| Jun 6, 2025 | JMP Securities | REITERATE | Market Perform | Market Perform |
| Feb 26, 2025 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Feb 26, 2025 | Roth MKM | REITERATE | Buy | Buy |
| Jan 22, 2025 | Canaccord Genuity | INITIATE | — | Buy |
| Nov 8, 2024 | Roth MKM | REITERATE | Buy | Buy |
| Nov 8, 2024 | Stifel | UPGRADE | Hold | Buy |
| May 8, 2024 | Roth MKM | UPGRADE | Neutral | Buy |
| Apr 22, 2024 | JMP Securities | REITERATE | — | Market Perform |
| Mar 7, 2024 | Roth MKM | MAINTAIN | Neutral | Neutral |
| Oct 20, 2023 | Roth MKM | INITIATE | — | Neutral |
| Sep 12, 2023 | BTIG | DOWNGRADE | Buy | Neutral |
| Sep 12, 2023 | Stifel | DOWNGRADE | Buy | Hold |
| Mar 4, 2022 | Stifel | UPGRADE | Hold | Buy |
| Oct 20, 2020 | Stifel | INITIATE | — | Hold |
| Feb 25, 2020 | Sidoti & Co. | MAINTAIN | — | Buy |
| Feb 25, 2020 | Cantor Fitzgerald | MAINTAIN | — | Neutral |
| Oct 29, 2019 | Cantor Fitzgerald | DOWNGRADE | Overweight | Neutral |
| Feb 26, 2019 | BTIG | DOWNGRADE | Buy | Neutral |
| Jun 1, 2018 | Cantor Fitzgerald | INITIATE | — | Overweight |
| Jun 21, 2017 | BTIG | INITIATE | — | Buy |
| Jun 14, 2017 | Ladenburg Thalmann | INITIATE | — | Buy |
| May 23, 2017 | SunTrust Robinson Humphrey | INITIATE | — | Buy |
| May 9, 2013 | JMP Securities | DOWNGRADE | Market Outperform | Market Perform |
| May 9, 2013 | Mizuho | DOWNGRADE | Buy | Neutral |
| May 9, 2013 | Janney Montgomery Scott | DOWNGRADE | Buy | Neutral |
| May 9, 2013 | Lazard | DOWNGRADE | Buy | Sell |
| Feb 25, 2013 | Piper Sandler | MAINTAIN | — | Neutral |
| Jan 3, 2013 | Lazard | MAINTAIN | — | Buy |
| Oct 31, 2012 | Piper Sandler | MAINTAIN | — | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 4 | 3 | 0 | 0 | 73% | |
| May 1, 2026 | 4 | 4 | 3 | 0 | 0 | 73% | |
| Apr 1, 2026 | 4 | 4 | 3 | 0 | 0 | 73% | |
| Mar 1, 2026 | 4 | 4 | 3 | 0 | 0 | 73% | |
| Feb 1, 2026 | 5 | 4 | 3 | 0 | 0 | 75% | |
| Jan 1, 2026 | 5 | 4 | 2 | 0 | 0 | 82% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 21, 2026
short_volume
Short Volume: OFIX — 57.6% short (0.3M / 0.6M)
Short: 342,000 | Exempt: 22,825 | TRF Vol: 593,838 | Short Ratio: 57.6% | Off-exchange volume (dark pool + OTC)
May 5, 2026
earnings_calendar
OFIX Q1 2026 Earnings Scheduled — 2026-05-05
Feb 24, 2026
earnings_calendar
OFIX Q4 2025 Earnings Before Market Open — 2026-02-24